Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti‐TNF therapy in a tuberculosis endemic region

BACKGROUND: Anti‐tumour necrosis factor (anti‐TNF) therapy increases the risk of tuberculosis (TB). Given limitations of screening techniques, it remains uncertain if patients receiving anti‐TNF in TB endemic regions should be screened for latent infection with chemoprophylaxis restricted to those w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Lingna, Chapman, Thomas P., Wen, Zhenzhen, Lin, Lang, Qiu, Yun, Liu, Zhanju, Ran, Zhihua, Qian, Jiaming, Wu, Kaichun, Gao, Xiang, Hu, Pinjin, Chen, Minhu, Travis, Simon P. L., Cao, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Targeted Chemoprophylaxis for Tuberculosis in IBD Patients Receiving Anti‐tnf
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839545/
https://www.ncbi.nlm.nih.gov/pubmed/33314259
http://dx.doi.org/10.1111/apt.16130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839545/
https://www.ncbi.nlm.nih.gov/pubmed/33314259
http://dx.doi.org/10.1111/apt.16130

Ejemplares similares